All In MedTech

FDA Clearance Tracker · P080025-S068

MEDTRONIC INTERSTIM THERAPY FOR BOWEL CONTROL

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Oct 17, 2014 (this decision)Source: openFDAMethods & limitations

PMA supplement

The decision

FDA number
P080025-S068
Device name
MEDTRONIC INTERSTIM THERAPY FOR BOWEL CONTROL
Applicant location
Minneapolis, MN
Received
Apr 21, 2014
Decided
Oct 17, 2014
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P080025

Device type

Device class
Class III
Regulation
21 CFR 876.5270

Every decision under product code QON

FDA's approval statement

As written in FDA's record.

APPROVAL FOR CHANGES TO THE MODEL 3037 ICON PATIENT CONTROLLER USED FOR MEDTRONIC INTERSTIM THERAPY FOR URINARY CONTROL AND BOWEL CONTROL.

Source documents

Other decisions for Medtronic Neuromodulation

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

2 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.